Evaluating Knowledge And Awareness Of SGLT-2 Inhibitors’ Use, Efficacy, Side Effects, And Cardiovascular And Renal Impacts Among Primary Healthcare Physicians In Makkah, Saudi Arabia. Rev Diabet Stud [Internet]. 2025 Jun. 10 [cited 2025 Dec. 8];:490-50. Available from: https://diabeticstudies.org/index.php/RDS/article/view/1081